Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (1491)	2/11/1999 3:23:00 PM
From: Mao II	Read Replies (1) \| Respond to of 2135

Max: It is really amazing to me what gets said on these boards, particularly by those who supposedly are guarding us all against the evils of "hype." Whether or not Angiostatin/Endostatin prove to be practical cancer treatments, Folkman is clearly a brilliant researcher with the kind of focused creativity that great scientists must have. And yes, this is vindication for him. I also think it casts BMY's exit in a somewhat different light. I for one would be interested in finding out if BMY exex knew this was coming. M2 (I have just a small stake in ENMD, by the way. I follow it because I have been fascinated by the melodrama playing out around it for the past year. A really remarkable story of money and greed and media and science.)